Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

EntreMed grants Oxford BioMedica gene rights for ophthalmic applications

Sep. 12, 2003

Good efficacy and safety profile described for ranibizumab in AMD

Sep. 3, 2003

Intravitreous hyaluronidase effective in reducing vitreous hemorrhage density

Sep. 3, 2003

VEGF Trap prevents blinding blood vessel growth in mice

Aug. 28, 2003

Improved vision in extension phase of Lucentis wet AMD study

Aug. 27, 2003

Priority review for Vitrase NDA

Aug. 25, 2003

Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial

Aug. 25, 2003

New phase III trial of loteprednol etabonate for allergic rhinitis

Aug. 21, 2003

Selective iNOS inhibitors show potential in the treatment of endotoxin-induced uveitis

Aug. 21, 2003

Phase IIIb results support use of diquafosol in dry eye

Aug. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...